Specialty drug prices commonly used by older adults in the U.S. have far outpaced the price increases of other goods and services over the last decade, according to AARP, which has been reporting on prescription drug price trends.

Out-of-pocket healthcare costs rose about 12% in 2018, according to a new TransUnion Healthcare analysis.

The shareholders of both Centene and WellCare Health Plans have approved a plan for the two companies to merge, they announced June 24. The deal is worth $17.3 billion and is expected to close in the first half of 2020.

Healthcare stocks are reeling following an executive order from President Trump that would give HHS the ability to require hospitals and health insurance companies to provide patients with prices for healthcare services based on negotiated rates.

As surprise billing solutions are more readily being talked about in Congress and among healthcare leaders in the industry, Americans are blaming their insurance companies for the problem, according to a recent survey from Morning Consult and the American College of Emergency Physicians.

HHS has sent its proposal to base certain drug prices on an international index to the White House last week, according to a report from The Hill.

Two major, global pharmaceutical companies ––AbbVie and Allergan––are merging in a deal worth approximately $63 billion.

President Trump's new executive order will enable HHS to require hospitals and insurers to disclose negotiated rates for healthcare services and give patients their out-of-pocket costs before their procedures, according to CNBC.